Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy November 8, 2023November 8, 2023
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study October 27, 2020August 16, 2022